Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan-based Helicobacter pylori eradication in penicillin-allergic patients
jRCTs031180133Completed
- Sponsor
- Yokohama City University
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of vonoprazan, clarithromycin, metronidazole and sitafloxacin in Helicobacter pylori infection, sponsored by Yokohama City University. Primary endpoint: Eradication rate. Started Mar 2015; status: completed.
02
Drugs
vonoprazanclarithromycinmetronidazolesitafloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on jRCTs031180133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180133.